These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37370390)

  • 1. Effect of Phenylalanine-Arginine Beta-Naphthylamide on the Values of Minimum Inhibitory Concentration of Quinolones and Aminoglycosides in Clinical Isolates of
    Plasencia-Rebata S; Levy-Blitchtein S; Del Valle-Mendoza J; Silva-Caso W; Peña-Tuesta I; Vicente Taboada W; Barreda Bolaños F; Aguilar-Luis MA
    Antibiotics (Basel); 2023 Jun; 12(6):. PubMed ID: 37370390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efflux Pump Inhibitor Phenylalanine-Arginine Β-Naphthylamide Effect on the Minimum Inhibitory Concentration of Imipenem in Acinetobacter baumannii Strains Isolated From Hospitalized Patients in Shahid Motahari Burn Hospital, Tehran, Iran.
    Gholami M; Hashemi A; Hakemi-Vala M; Goudarzi H; Hallajzadeh M
    Jundishapur J Microbiol; 2015 Oct; 8(10):e19048. PubMed ID: 26568800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of Phenylalanine-arginine-beta-naphthylamide to Ciprofloxacin Minimum Inhibitory Concentration Values and Expression of Efflux Pump System Genes in Acinetobacter baumannii Isolates].
    Kaynak Onurdağ F; Kayış U; Ökten S
    Mikrobiyol Bul; 2021 Jul; 55(3):285-299. PubMed ID: 34416797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and diversity of mutations in regulatory genes of resistance-nodulation-cell division efflux pumps in association with drug-resistant clinical isolates of Acinetobacter baumannii.
    Salehi B; Ghalavand Z; Yadegar A; Eslami G
    Antimicrob Resist Infect Control; 2021 Mar; 10(1):53. PubMed ID: 33691788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of the efflux pump inhibitor phenylalanine-arginine β-naphthylamide against the AdeFGH pump of Acinetobacter baumannii.
    Cortez-Cordova J; Kumar A
    Int J Antimicrob Agents; 2011 May; 37(5):420-4. PubMed ID: 21377839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of highly ciprofloxacin resistance acinetobacter baumannii isolated from patients with burn wound infections in presence and absence of efflux pump inhibitor.
    Maleki MH; Jalilian FA; Khayat H; Mohammadi M; Pourahmad F; Asadollahi K; Pakzad I; Sadeghifard N; Soroush S; Emaneini M; Taherikalani M
    Maedica (Bucur); 2014 Jun; 9(2):162-7. PubMed ID: 25705272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efflux pump inhibitor phenylalanine-arginine β-naphthylamide (PAβN) increases resistance to carbapenems in Chilean clinical isolates of KPC-producing Klebsiella pneumoniae.
    Vera-Leiva A; Carrasco-Anabalón S; Lima CA; Villagra N; Domínguez M; Bello-Toledo H; González-Rocha G
    J Glob Antimicrob Resist; 2018 Mar; 12():73-76. PubMed ID: 29275225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Investigation of fluoroquinolone resistance mechanisms in clinical Acinetobacter baumannii isolates].
    Güler G; Eraç B
    Mikrobiyol Bul; 2016 Apr; 50(2):278-86. PubMed ID: 27175500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii.
    Rumbo C; Gato E; López M; Ruiz de Alegría C; Fernández-Cuenca F; Martínez-Martínez L; Vila J; Pachón J; Cisneros JM; Rodríguez-Baño J; Pascual A; Bou G; Tomás M; ; ;
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5247-57. PubMed ID: 23939894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Efflux Pump Inhibitor Carbonyl Cyanide 3-Chlorophenylhydrazone on the Minimum Inhibitory Concentration of Ciprofloxacin in Acinetobacter baumannii Clinical Isolates.
    Ardebili A; Talebi M; Azimi L; Rastegar Lari A
    Jundishapur J Microbiol; 2014 Jan; 7(1):e8691. PubMed ID: 25147654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of efflux pumps in reduced susceptibility to tigecycline in
    Ardehali SH; Azimi T; Fallah F; Owrang M; Aghamohammadi N; Azimi L
    New Microbes New Infect; 2019 Jul; 30():100547. PubMed ID: 31193724
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular Detection of
    Kaviani R; Pouladi I; Niakan M; Mirnejad R
    Rep Biochem Mol Biol; 2020 Jan; 8(4):413-418. PubMed ID: 32582800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic and WGS-derived antimicrobial resistance profiles of clinical and non-clinical Acinetobacter baumannii isolates from Germany and Vietnam.
    Wareth G; Linde J; Hammer P; Nguyen NH; Nguyen TNM; Splettstoesser WD; Makarewicz O; Neubauer H; Sprague LD; Pletz MW
    Int J Antimicrob Agents; 2020 Oct; 56(4):106127. PubMed ID: 32750418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features.
    Boral B; Unaldi Ö; Ergin A; Durmaz R; Eser ÖK;
    Ann Clin Microbiol Antimicrob; 2019 Jul; 18(1):19. PubMed ID: 31266519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of the efflux pump inhibitor Carbonyl Cyanide m-Chlorophenylhydrazone (CCCP) on the susceptibility to imipenem and cefepime in clinical strains of Acinetobacter baumannii.
    Sanchez-Carbonel A; Mondragón B; López-Chegne N; Peña-Tuesta I; Huayan-Dávila G; Blitchtein D; Carrillo-Ng H; Silva-Caso W; Aguilar-Luis MA; Del Valle-Mendoza J
    PLoS One; 2021; 16(12):e0259915. PubMed ID: 34919563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
    Keskin H; Tekeli A; Dolapci İ; Öcal D
    Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigation of oxacillinase genes in nosocomial multidrug-resistant Acinetobacter baumannii isolates by multiplex PCR and evaluation of their clonal relationship with Rep-PCR].
    Sarı B; Baran I; Alaçam S; Mumcuoğlu İ; Kurşun Ş; Aksu N
    Mikrobiyol Bul; 2015 Apr; 49(2):249-58. PubMed ID: 26167825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antimicrobial susceptibility and molecular characterization of multidrug-resistant Acinetobacter baumannii isolated in an university hospital].
    Direkel Ş; Çopur Çiçek A; Karagöz A; Aydoğan Ejder N; Oktay E; Delialioğlu N; Özgümüş OB; Durmaz R
    Mikrobiyol Bul; 2016 Oct; 50(4):522-534. PubMed ID: 28124957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of efflux-mediated ciprofloxacin and levofloxacin resistance in recent clinical isolates of Pseudomonas aeruginosa and its reversal by the efflux pump inhibitors 1-(1-naphthylmethyl)-piperazine and phenylalanine-arginine-β-naphthylamide.
    Sonnet P; Izard D; Mullié C
    Int J Antimicrob Agents; 2012 Jan; 39(1):77-80. PubMed ID: 21974858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole Genome Analysis of Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates in Thailand.
    Chopjitt P; Kerdsin A; Takeuchi D; Hatrongjit R; Boueroy P; Akeda Y; Tomono K; Hamada S
    Infect Disord Drug Targets; 2021; 21(5):e270421188042. PubMed ID: 33200701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.